Neutrophil-to-Lymphocyte Ratio not associated with Early Diagnosed Prostatic Carcinoma Patients

Gihan Mossalami  Mohammed; Sakina Mustafa  Abdelrhman; NasrEldeen Ali Mohammed  Gaufri

doi:10.52981/smlj.v8i1.2559

Gihan Mossalami Mohammed Department of Hematology, Faculty of Medical Laboratory Sciences, Ibn Sina University, Khartoum, Sudan
Sakina Mustafa Abdelrhman Department of Hematology, Faculty of Medical Laboratory Sciences, Al-Neelain University, Khartoum, Sudan
NasrEldeen Ali Mohammed Gaufri Department of Hematology, Faculty of Medical Laboratory Sciences, Ibn Sina University, Khartoum, Sudan

DOI: https://doi.org/10.52981/smlj.v8i1.2559

Keywords: Prostate cancer, Neutrophil-to-Lymphocyte, chemiluminescence

Abstract

Background: Prostate cancer has become the most common malignancy among men in several developed countries especially Sudan. The neutrophils lymphocytes ratio (NLR) was one of recent inflammatory biomarkers, nowadays was used as predictor and prognostic tools in different malignant disorders Aim: This study was aimed to assess the neutrophils to lymphocytes ratio in early diagnosed prostatic carcinoma patients. Materials and Methods: This study is descriptive case control study, was conducted at Almoalim Medical City (AMC) Khartoum, Sudan. One hundred males, fifty were known prostatic cancer patients (early diagnosed) used as case group. Others fifty were normal healthy male matched the case group in age used as normal control group. The complete blood count (CBC) was done from EDTA anticoagulated blood samples and NLR was calculated using automated Hematology analyzer SYSMEX NX-550, prostate specific antigen was estimated using (chemiluminescence) e411 Cobas, all laboratory tests were made under fully quality control procedures. Data was collected by using direct structured questionnaire. Data was analyzed by SPSS version 18 and the significant value was present when the P. value less than 0.05. Result: This study showed that the Neutrophils Lymphocytes ratio (NLR) and absolute lymphocytes were insignificant different in the early diagnosed prostatic carcinoma patients compared with normal non prostate cancer with p value more than 0.05 while the absolute neutrophils was showed a statistically significant different between case and control with p value 0.03. Conclusion: This study concluded that the neutrophils lymphocytes ratio (NLR) may not applicable as predictor prognostic marker for the early diagnosed prostatic carcinoma patients.

References

1-Harper, Douglas. "Prostate". Online Etymology Dictionary. Retrieved 2013-11-03.
2- Romer, Alfred Sherwood; Parsons, Thomas S. (1977). The Vertebrate Body. Philadelphia, PA: Holt-Saunders International. p. 395. ISBN 978-0-03-910284-5.
3- Tsukise, A.; Yamada, K. (1984). "Complex carbohydrates in the secretory epithelium of the goat prostate". The Histochemical Journal. 16 (3): 311–9.doi:10.1007/BF01003614. PMID 6698810.
4- Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer.2019 Apr 15; 144(8):1941-1953
5-Adeloye D, David RA, Aderemi AV, Iseolorunkanmi A, Oyedokun A, Iweala EE, Omoregbe N, Ayo CK. An Estimate of the Incidence of Prostate Cancer in Africa: A Systematic Review and Meta-Analysis.PLoS One. 2016 Apr13;11(4):e0153496.
6- Boyle, P., and B. Levin. 2008. World cancer report 2008. IARC Press, International Agency for Research on Cancer, Lyon, France.
7- Wang J1, Zhou X, He Y, Chen X, Liu N, Ding Z, Li J. Prognostic role of platelet to lymphocyte ratio in prostate cancer A meta-analysis, Medicine (2018) 97:40(e12504)
8- Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global Cancer Statistics, 2012. CA Cancer J Clin 2015; 65:87–108.
9- Tsodikov A, Gulati R, Heijnsdijk EAM, Pinsky PF, Moss SM, Qiu S, de Carvalho TM, Hugosson J, Berg CD, Auvinen A, Andriole GL, Roobol MJ, Crawford ED, Nelen V, Kwiatkowski M, Zappa M, Luján M, Villers A, Feuer EJ, de Koning HJ, Mariotto AB, Etzioni R. Reconciling the effects of screening on prostate cancer mortality in the ERSPC and PLCO trials. Annals of Internal Medicine 2017; 167(7):449-455.
10- Klein EA, Chait A, Hafron JM, Kernen KM, Manickam K, Stephenson AJ, Wagner M, Zhu H, Kestranek A, Zaslavsky B, Stovsky M. The single-parameter, structure-based IsoPSA assay demonstrates improved diagnostic accuracy for detection of any prostate cancer and high-grade prostate cancer compared to a concentration-based assay of total prostate-specific antigen: A preliminary report. European Urology 2017; S0302-283 8(17)30236,1.
11- Bain B J. The peripheral blood smear. In Goldman L, Schafer AI. (© 2012). Goldman's Cecil Medicine 24th Edition: Elsevir Saunders, Philadelphia, PA. Pp 1024-1031.
12- Pagana, Kathleen D., Pagana, Timothy J, and Pagana, Theresa N. (© 2015). Mosby's Diagnostic and Laboratory Test Reference 12th Edition: Mosby, Inc., Saint Louis, MO. Pp 497-501, 786-789, 991-995.
13- Jeong Soo Lee, Na Young Kim, Se Hee Na, Young Hoon Youn, Cheung Soo Shin, Reference values of neutrophil-lymphocyte ratio, lymphocyte-monocyte ratio, platelet-lymphocyte ratio, and mean platelet volume in healthy adults in South Korea, Medicine (Baltimore) 2018 Jun; 97(26): e11138. Published online 2018 Jun 29.
14- Bhat T, Teli S, Rijal J, Bhat H, Raza M, Khoueiry G, Meghani M, Akhtar M, Costantino T., Neutrophil to lymphocyte ratio and cardiovascular diseases: a review, Expert Rev Cardiovasc Ther. 2013 Jan;11(1):55-9. doi: 10.1586/erc.12.159.
15- Xiaotao Yin, Yi Xiao, Fanglong Li, Siyong Qi, Zhaoyang Yin, and Jiangping Gao, Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Prostate Cancer, A Systematic Review and Meta-analysis, Medicine, Volume 95, Number 3, January 2016
16- MJ Proctor, DC McMillan, DS Morrison, CD Fletcher, PG Horgan,SJ Clarke, A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer, British Journal of Cancer (2012) 107(4), 695 – 699
17- Jing Chen, Dongsheng Hong, You Zhai Peng Shen, Meta-analysis of associations between, neutrophil-to-lymphocyte ratio and prognosis of gastric cancer, World Journal of Surgical Oncology (2015) 13:12
18. van der Valk P, Herman CJ. Leukocyte functions. Lab Invest. 1987;56:127–3.[PubMed] [Google Scholar]
19. Kim R, Emi M, Tanabe K. Cancer immuno editing from immune surveillance to immune escape. Immunology. 2007;121:1–14. [PMC free article] [PubMed] [Google Scholar]
20- Daniele Minardi, M Scartozzi, L Montesi, M Santoni, L Burattini, M Bianconi, V Lacetera, G Milanese, S Cascinu, G Muzzonigro. Neutrophil-to-lymphocyte ratio may be associated with the outcome in patients with prostate cancer. Springerplus. 2015;4:255.
21. Linton A, Pond G, Clarke S, Vardy J, Galsky M, Sonpavde G. Glasgow prognostic score as a prognostic factor in metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy. Clin Genitourin Cancer. 2013;11:423–430.
22- Arnoud J. Templeton, Carmel Pezaro, Aurelius Omlin, Mairéad G. McNamara ,Raya Leibowitz‐ Amit , Francisco E. Vera‐Badillo, Gerhardt Attard , Johann S. de Bono MB ChB, Ian F. Tannock MD, Eitan Amir.Simple prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil-to-lymphocyte ratio. Cancer. 2014; 120:3346–3352.
23- Lord BI, Bronchud MH, Owens S, Chang J, Howell A, Souza L, Dexter TM. The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. Proc Natl Acad Sci U S A. 1989 Dec;86(23): 9499-503.
24- An X, Ding PR, Li YH, Wang FH, Shi YX, Wang ZQ, He YJ, Xu RH, Jiang WQ. Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer. Biomarkers. 2010;15:516–522.
25- Mehmet Ilker Gokce, Nurullah Hamidi, Evren Suer, Semih Tangal, Adil Huseynov, Arif Ibiş, Evaluation of neutrophil-to-lymphocyte ratio prior to prostate biopsy to predict biopsy histology: Results of 1836 patients, Can Urol Assoc J 2015;9(11-12):E761-5